Reducing Attrition Rates in Anticancer Drug Discovery and Development: IMI Approaches

Dr. J.C. Waterton, AstraZeneca, Macclesfield, United Kingdom, presents on behalf of the QuIC-ConCePT Consortium at the 24th EORTC – NCI – AACR Symposium on Molecular Targets and Cancer Therapeutics held 6 – 9 November 2012 in Dublin, Ireland.

IMI oncology projects